يعرض 1,161 - 1,180 نتائج من 21,342 نتيجة بحث عن '(( significant decrease decrease ) OR ( significantly elevated decrease ))*', وقت الاستعلام: 0.41s تنقيح النتائج
  1. 1161
  2. 1162

    DDC for four anticoagulants from 2019 to 2023. حسب Wei Luo (80175)

    منشور في 2025
    الموضوعات:
  3. 1163
  4. 1164

    Raw Data. حسب Chen Lu (135200)

    منشور في 2025
    الموضوعات:
  5. 1165

    Utilization of anticoagulants from 2019 to 2023. حسب Wei Luo (80175)

    منشور في 2025
    الموضوعات:
  6. 1166

    The description of games. حسب Sadaf Sepasgozar Sarkhosh (20436143)

    منشور في 2024
    الموضوعات:
  7. 1167
  8. 1168
  9. 1169
  10. 1170

    Association between FF Proximity and BMI by sex. حسب Kimberly Yuin Y’ng Wong (22766265)

    منشور في 2025
    "…An exponential decrease in FF proximity was associated with 0.7 kg/m<sup>2</sup> (p < 0.001) increase in BMI among males and 0.4 kg/m<sup>2</sup> (p < 0.05) decrease among females. …"
  11. 1171

    Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms حسب Farman M. Abbasi (22318766)

    منشور في 2025
    "…Postmenopausal osteoporosis (PMO) is characterized by an imbalance in bone remodeling with increased osteoclast and decreased osteoblast activity, leading to bone loss and higher fracture risk. …"
  12. 1172

    Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms حسب Farman M. Abbasi (22318766)

    منشور في 2025
    "…Postmenopausal osteoporosis (PMO) is characterized by an imbalance in bone remodeling with increased osteoclast and decreased osteoblast activity, leading to bone loss and higher fracture risk. …"
  13. 1173

    Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms حسب Farman M. Abbasi (22318766)

    منشور في 2025
    "…Postmenopausal osteoporosis (PMO) is characterized by an imbalance in bone remodeling with increased osteoclast and decreased osteoblast activity, leading to bone loss and higher fracture risk. …"
  14. 1174
  15. 1175

    Fig 11 - حسب Naveed Arshad (19712985)

    منشور في 2024
    الموضوعات:
  16. 1176
  17. 1177
  18. 1178
  19. 1179
  20. 1180